We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLms Capital Regulatory News (LMS)

Share Price Information for Lms Capital (LMS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.10
Bid: 18.10
Ask: 19.00
Change: -0.35 (-1.90%)
Spread: 0.90 (4.972%)
Open: 18.10
High: 18.10
Low: 18.10
Prev. Close: 18.45
LMS Live PriceLast checked at -
LMS Capital is an Investment Trust

To achieve absolute total returns over the medium to longer term, principally through capital gains and supplemented with the generation of a longer term income yield, by investing primarily in private equity.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Net Asset Value(s)

7 Feb 2023 07:00

RNS Number : 0842P
LMS Capital PLC
06 February 2023
 

 

 

 

7 February 2023

 

LMS CAPITAL PLC

NAV Estimate as at 31 December 2022

 

LMS Capital plc (the "Company" or "LMS") the listed investment company provides the following update and estimate of net asset value ("NAV") as at 31 December 2022.

 

Net Asset Value Estimate

 

The Company has commenced the year end valuation review process which is based on the latest performance updates from portfolio companies and third-party fund manager valuations.

 

The Board currently estimates that the year end NAV will be in the region of £46.6m (2021: £49.1 million) which equates to 57.7p per share (2021: 60.8p per share). This represents a reduction of 3.7% on the prior year after adjusting for dividends paid and reflects information currently available to the Board on the performance of individual investments in the Company's portfolio and is subject to further evaluation as well as completion of the annual audit.

 

The performance is summarised below:

 

Preliminary

31 December 2022

 

Unaudited

30 June 2022

Audited

31 December 2021

£ 'm

NEW INVESTMENTS - DACIAN

10.1

9.4

7.9

MATURE ASSET PORTFOLIO

20.8

20.8

23.0

Total Investment Portfolio

30.9

30.2

30.9

Cash

17.9

18.9

20.1

Other Net Assets/Liabilities 

(2.2)

(2.1)

(1.9)

Net Asset Value

46.6

47.0

49.1

Pence per Share

57.7p

58.2p

60.8p

 

The valuation methodology and policy adopted is consistent with prior years and is in line with IPEV guidelines. The carrying value of the funds is based on the latest available information from the respective fund managers, generally the 30 September 2022 fund valuation reports except for Weber, a fund of listed US investments, which is based on a 31 December 2022 valuation.

 

Overview

 

· Dacian

2022 was the first full year of operation for Dacian, the Romanian oil and gas production company in which LMS holds $9.1 million of senior loan notes and 32% of the ordinary shares.

Dacian has been profitable and cash generative during its first year, energy prices remain substantially higher than when the acquisition was underwritten in August 2020;

As reported in our half year and Q3 announcements, backlog maintenance problems, inherited on takeover of the estate, have interrupted production in some wells and in the short term have diverted the company's resources from its planned workover projects to develop the fields and expand production. However, as a result of management actions during Q2 and Q3, Dacian believe that production is stabilising and expect to devote resources to development activities with the aim of producing production gains during 2023;

During the year the Company has recognised £1.3 million of accrued interest on its loan notes;

The Board expects the investment to meet or exceed the Company's medium-term return targets over its life.

 

· Mature asset portfolio

Overall, taking account of foreign exchange movements and underlying valuation changes over the year, the mature asset portfolio showed a net reduction in value of £1.3 million. Information on the movements by asset is included in note 1 below;

The mature asset portfolio comprises assets for the large part managed by third-party managers and 82% of which is in the three largest positions, Brockton, Medhost and Opus. LMS does not control the realisation process but maintains a close dialogue with the managers. Our expectation is that there may be some liquidity in 2023, although greater liquidity is more likely in 2024 and 2025.

 

· Running costs were net £1.7 million (2021: £1.8 million) in line with budget and remain strictly controlled. 2022 showed a reduction compared to the prior year as the benefits of income from the Company's co-investment activities began to be realised.

 

· Cash balances were £17.9 million, 22p per share, (31 December 2021: £20.1 million)

 

Deployment of capital

 

In our half year report we referenced opportunities in real estate development and investment; we have continued to develop both activities.

 

· Real estate development - the retirement living sector offers an opportunity with strong demand drivers, where our experience in land assembly, planning, design and development of specialist use real estate can be deployed alongside sector operating knowhow. We have assembled an advisory group, which has screened a number of opportunities during the year and we are currently in discussion on a small number of potential projects. In evaluating potential opportunities we are mindful of the risks, in particular around escalating construction costs and a slowing housing market. We will only take forward opportunities that offer risk adjusted returns that meet the Company's long-term return criteria.

 

· Real estate investment - we have been working with our real estate investment team to establish an investment platform which will allow LMS to bring co-investment capital, alongside its own investment, on a deal by deal basis. We believe the market in 2023 will create some attractive buying opportunities.

 

· Energy - in the medium term we anticipate further "late life" oil and gas production opportunities with the Dacian team although the priority for 2023 is to achieve the target production gains on the existing assets.

 

Outlook

 

The Board is aware of the impact on overall returns of the Company's uninvested cash. However it remains disciplined and focussed on ensuring capital is deployed in areas where the Company has clear competitive advantage, in particular in energy and in real estate, and in the longer term will generate attractive returns for investors.

 

The Dacian team has now completed its first year of operation and believes that it is well positioned in 2023 to demonstrate the production gains that underpin the investment case for this asset. In real estate we are cautious about market conditions but see opportunities and expect to deploy capital during the year alongside our real estate industry partners.

 

Further information on the performance of the portfolio, underlying investment valuations and changes during the year will be included in the Company's audited results for the year ended 31 December 2022, which it expects to announce in March 2023.

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

For further information please contact:

 

LMS Capital plc

Nick Friedlos, Managing Director

0207 935 3555

 

Note 1 - NAV changes and portfolio summary

 

Overall, for the year as a whole, the Company's NAV, after adding back dividends paid, has decreased by £1.8

million, 3.7%. The principal components of the full year change are described below.

 

· Foreign exchange net gains on the investment portfolio during the year were £2.8 million. 76% of the Company's investment portfolio is denominated in US Dollars.

 

· Excluding the effect of foreign exchange rate changes, the mature asset portfolio showed a net reduction of £4.1 million in the year. The principal elements were:

An increase of £0.5 million in Brockton reflecting the unwinding of the discounted cash flows;

An increase of £0.8 million in the valuation of the Opus Capital Venture Partners fund. This fund has two principal remaining investments, both of which are performing well and the manager believes, subject to market conditions, have good prospects for realisation;

Decreases totalling £2.3 million on two assets reflecting actual or imminent disposal values

§ £1.8 million on ICU which is being sold by SFEP, anticipated to conclude imminently, and will produce proceeds of approximately £0.3 million for LMS. This is a disappointing outcome and a poor result from the fund. ICU is the last SFEP asset in the portfolio;

§ £0.5 million reduction in value of Eden Ventures fund which sold its last remaining asset in Q4 2022.

A decrease of £0.9 million in Weber Capital Partners, a US listed small cap fund. The decrease reflects quoted market price changes during the year;

A decrease of £0.7 million reflecting a reduction in the valuation of Medhost by Primus, the lead manager. The company operates in a mature market and continues to be profitable and cash generative and is performing in line with budget;

A decrease of £0.6 million in the valuation of Elateral; and

Other portfolio net reductions were £0.9 million.

 

· Interest accrued on Dacian amounted to £1.3 million.

 

· Other movements were a net reduction of £1.8 million and include the following:

Full year running costs were £1.7 million;

Investment support costs (support costs for real estate and co-investment activities) were £0.4 million; and

Other movements include unrealised foreign exchange gains of £0.4 million on non-portfolio assets, principally US Dollar bank accounts, £0.3 million tax payable, and £0.2 million of bank interest receivable.

 

Quoted Investments

 

Investment

31 Dec 2022

£' m

30 June 2022

£' m

31 Dec 2021

£'m

IDE Group (now Tialis)

0.1

0.1

0.2

Other

3 small holdings

0.1

0.1

0.2

Total

 

 

0.2

0.2

0.4

 

Unquoted Investments

 

Investment

31 Dec 2022

£' m

30 June 2022

£' m

31 Dec 2021

£'m

Dacian Petroleum

USD

Onshore oil and gas production assets in Romania

10.1

9.4

7.9

Medhost

USD

Provides cloud based enterprise and departmental management and healthcare engagement solutions to community hospitals in the US.

5.7

5.3

6.0

Elateral

Sterling

UK/US software company in the digital marketing sector providing marketing content management solutions

0.6

0.6

0.8

ICU

USD

Design and distribution of eyewear, principally reading glasses, through large US retailers

0.2

 

0.6

1.7

Other investments

USD/

Sterling

0.1

0.2

0.1

Total

 

 

16.7

16.1

16.5

 

Funds 

 

Investment

Currency

31 Dec 2022

£' m

30 June 2022

£' m

31 Dec 2021

£'m

Brockton Capital Fund 1

Sterling

UK real estate fund, the remaining asset of which is a debt investment in a high end London residential development

6.0

6.0

5.6

Opus Venture Capital Fund 2

USD

Early-stage technology fund with two principal remaining assets

5.3

5.4

3.9

Weber Capital Partners

USD

US listed microcap investment fund focussed primarily on medical and technology sectors

2.0

1.8

2.6

Other investments

USD/

Sterling

0.7

0.8

1.8

Total

 

 

14.0

14.0

13.9

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVSSDFAMEDSELE
Date   Source Headline
25th Apr 20244:09 pmRNSInvestor Presentation
25th Apr 20243:10 pmRNSHolding(s) in Company
24th Apr 20244:42 pmRNSNotice of AGM
19th Mar 20247:00 amRNS2023 Final Results
8th Mar 20242:23 pmRNSHolding(s) in Company
23rd Feb 20247:00 amRNSNet Asset Value(s)
29th Jan 20247:00 amRNSPortfolio Update - Brockton Fund 1
27th Dec 20237:00 amRNSPortfolio Update
21st Dec 20237:00 amRNSRetirement living investment platform
30th Oct 20237:00 amRNSThird Quarter 2023 Update
16th Aug 20233:11 pmRNSLong Term Incentive Plan Awards
1st Aug 20237:00 amRNSHalf year results for the 6 months ended 30.06.23
23rd May 20234:03 pmRNSDividend Declaration - REPLACEMENT
18th May 20234:08 pmRNSDividend Declaration
18th May 20234:03 pmRNSResult of AGM
5th May 20237:00 amRNSStatement re Notice to shareholders
28th Apr 20237:00 amRNSFirst Quarter 2023 Update
24th Apr 20232:42 pmRNSNotice of AGM
24th Apr 20232:37 pmRNSNotice of AGM
14th Apr 202310:47 amRNSHolding(s) in Company
22nd Mar 20233:04 pmRNSHolding(s) in Company
20th Mar 20237:00 amRNSFinal Results fo rthe Year Ended 31 December 2022
7th Feb 20237:00 amRNSNet Asset Value(s)
25th Nov 20223:54 pmRNSHolding(s) in Company
28th Oct 20227:00 amRNSThird Quarter 2022 Update
2nd Aug 20227:09 amRNSHalf year Report and Dividend declaration
19th May 20223:42 pmRNSDividend Declaration
18th May 20224:27 pmRNSResult of AGM
27th Apr 20227:00 amRNSFirst Quarter 2022 Update
22nd Apr 20227:00 amRNSNotice of Annual General Meeting 2022
10th Mar 20227:00 amRNSFinal Results for the Year Ended 31 December 2021
31st Jan 20227:00 amRNSNAV Estimate as at 31 December 2021
15th Dec 20214:41 pmRNSSecond Price Monitoring Extn
15th Dec 20214:36 pmRNSPrice Monitoring Extension
23rd Nov 20217:00 amRNSPortfolio Update
12th Nov 202112:34 pmRNSPortfolio Update
22nd Oct 20217:00 amRNSThird Quarter 2021 Update
23rd Sep 202112:16 pmRNSHolding(s) in Company
4th Aug 20217:00 amRNSDividend Declaration
3rd Aug 20217:00 amRNSHalf-year Report
8th Jul 202110:16 amRNSChange of Registered Office
18th May 20214:36 pmRNSPrice Monitoring Extension
13th May 20213:32 pmRNSFinal Dividend for the year ended 31 December 2020
12th May 20214:20 pmRNSResult of AGM
29th Apr 20217:00 amRNSFirst Quarter 2021 Update
9th Apr 20217:00 amRNSAnnual Financial Report
31st Mar 20214:41 pmRNSSecond Price Monitoring Extn
31st Mar 20214:35 pmRNSPrice Monitoring Extension
12th Mar 20217:09 amRNSFinal Results for the Year Ended 31 December 2020
2nd Mar 20214:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.